|ITEM METADATA RECORD
|Title: ||Vandetanib plus pemetrexed vs pemetrexed as 2nd-line therapy in patients with advanced non-small-cell lung cancer (NSCLC); a randomized, double-blind phase III trial|
|Authors: ||Vansteenkiste, Johan|
Blackhall, F. H
Yang, C. H
de Boer, R. H #
|Issue Date: ||Sep-2009 |
|Host Document: ||European Journal of Cancer Supplements vol:7 issue:2 pages:506-506|
|Conference: ||- edition:- location:- date:-|
|Publication status: ||published|
|KU Leuven publication type: ||IMa|
|Appears in Collections:||Pneumology|
|Files in This Item:
There are no files associated with this item.
All items in Lirias are protected by copyright, with all rights reserved.
© Web of science